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Abstract
Background: There is an unmet need for suitable ex vivo large animal models in experimental gastroenterology and intestinal
transplantation. This study details a reliable and effective technique for ex vivo normothermic perfusion (EVNP) of segmental porcine
small intestine.
Methods: Segments of small intestine, 1.5–3.0 m in length, were retrieved from terminally anaesthetized pigs. After a period of cold
ischaemia, EVNP was performed for 2 h at 37C with a mean pressure of 80 mmHg using oxygenated autologous blood diluted with
Ringer’s solution. The duration of EVNP was extended to 4 h for a second set of experiments in which two segments of proximal
to mid-ileum (1.5–3.0 m) were retrieved from each animal and reperfused with whole blood (control) or leucocyte-depleted blood to
examine the impact of leucocyte depletion on reperfusion injury.
Results: After a mean cold ischaemia time of 5 h and 20 min, EVNP was performed in an initial group of four pigs. In the second set
of experiments, five pigs were used in each group. In all experiments bowel segments were well perfused and exhibited peristalsis
during EVNP. Venous glucose levels significantly increased following luminal glucose stimulation (mean(s.e.m.) basal level 1.8(0.6)
mmol/l versus peak 15.5(5.8) mmol/l; P< 0.001) and glucagon-like peptide 1 (GLP-1) levels increased in all experiments, demonstrating
intact absorptive and secretory intestinal functions. There were no significant differences between control and leucocyte-depleted
animals regarding blood flow, venous glucose, GLP-1 levels or histopathology at the end of 4 h of EVNP.
Conclusions: This novel model is suitable for the investigation of gastrointestinal physiology, pathology and ischaemia reperfusion
injury, along with evaluation of potential therapeutic interventions.
Introduction
There is increasing appreciation of the multitude of complex
physiological roles of the intestine, both in health and in disease.
These include the involvement of enteroendocrine cells in the reg-
ulation of appetite, gut motility and insulin secretion1; the inter-
play between intestinal immune cells, the microbiota and
inflammation2; and the functions of regulatory cell populations in
maintaining the immune tolerance of the intestinal mucosa3.
Optimal study of such complex biological processes requires ac-
cess to functional experimental models amenable to close moni-
toring and manipulation. Much of the experimental data in these
areas currently derives from small animal models, in part due to
lack of appropriate ex vivo large animal models. While informa-
tive, extrapolation and direct clinical translation of experimental
findings from small animals to humans is inherently challenging.
The last decade has also seen a dramatic increase in small
bowel transplantation as a treatment option for patients with
short bowel syndrome who have failed parenteral nutrition, ei-
ther due to loss of vascular access or irreversible liver damage.
Short-term outcomes have steadily improved and 1-year patient
survival after isolated small bowel transplantation is now ap-
proximately 80 per cent4. Long-term outcomes, however, remain
poor with little improvement in recent years, probably reflecting
combinations of ischaemia–reperfusion (IR) injury, rejection, in-
fection and graft-versus-host disease. If long-term results are to
be improved, it is vital that appropriate functional large animal
models are available to allow investigation of the mechanisms
underlying these processes in order to identify and evaluate po-
tential interventions.
Blood-based ex vivo normothermic perfusion (EVNP) has been
shown to be a suitable technique for the study of isolated organs
under controlled perfusion conditions. Such a model, when opti-
mized, can potentially enable investigation of IR injury, organ
physiology and possible therapeutic strategies. Reliable EVNP
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models using a blood-based solution have been established in
large animals or humans for kidney5,6, liver7,8, heart9,10 and
lung11,12. In addition to being a useful tool for research, EVNP has
been shown to have therapeutic benefit in improving function of
marginal human kidneys13 and livers14. The potential utility of
EVNP for the functional study of human pancreases has also
been reported15. The aim of this study was therefore to examine
the feasibility of EVNP of isolated porcine small bowel segments
as a similar experimental model.
Previous EVNP studies of pig and human kidney kidneys have
demonstrated that depletion of leucocytes prior to perfusion can
ameliorate IR injury16,17. As leucocytes are a source of reactive
oxygen species production18,19, this may partially explain the pro-
tective effect of leucocyte depletion in these studies. Therefore, a
second aim of the current study was to examine the impact of
leucocyte depletion on small bowel IR injury using this model.
Methods
Small intestine retrieval
Approval for the study was granted under the UK Animal
(Scientific Procedures) Act 1986. Nine young adult male white pigs
(50–60 kg; n¼ 9) were used. A midline laparotomy was performed
under general anaesthesia. Following systemic anticoagulation
with 25 000 units of unfractionated heparin sodium in 5 ml of so-
lution (Wockhardt UK Ltd, Wrexham, UK) the distal aorta was
cannulated with a 14 French Soft-FlowVR arterial cannula
(Medtronic UK, Watford, UK). The pig was then exsanguinated via
the aortic cannula and the blood collected into a sterile receptacle.
Asystole was confirmed, the descending thoracic aorta cross-
clamped and in situ perfusion initiated with 2 litres of hyperosmo-
lar citrate solution (SoltranVR ; Baxter Healthcare, Thetford, UK) fol-
lowed by 2 litres of University of Wisconsin solution (CoStorSolVR ;
Bridge To Life, London, UK). The abdomen was packed with
crushed ice to aid organ cooling. Once cold perfusion was com-
plete, segments of proximal to mid-ileum (1.5–3.0 m) were isolated
and resected with intact mesenteric vascular arcades suitable for
cannulation. Those segments of small bowel were then stored in
cooled hyperosmolar citrate solution (SoltranVR , Baxter Healthcare,
Thetford, UK) and transported in crushed ice at 4C. To examine
the impact of perfusion with leucocyte-depleted blood on IR in-
jury, two consecutive 1.5-m segments of small intestine were re-
trieved from each of five pigs in the second sets of experiments.
EVNP circuit
A customised EVNP circuit based on commercially available pae-
diatric cardiopulmonary bypass was used (Medtronic UK,
Watford, UK). The system consisted of an organ chamber, venous
reservoir, centrifugal blood pump, membrane oxygenator and
heat exchanger. The perfusate contained autologous porcine
whole or leucocyte-depleted blood mixed with Ringer’s solution
for infusionTM (Baxter Healthcare, Thetford, UK), cefuroxime
(ZinacefVR , GlaxoSmithKline, Brentford, UK), 8.4 per cent sodium
bicarbonateTM (Sigma-Aldrich, Gillingham, UK) and 5 per cent glu-
cose w/v Intravenous InfusionTM (Baxter Healthcare, Thetford,
UK). After a period of cold ischaemia, benchwork was performed
with the organ cooled on ice. The proximal mesenteric artery was
cannulated using a 14 French Soft-FlowVR arterial cannula
(Pennine Healthcare, Derby, UK), the distal artery was ligated and
the graft flushed with GelofusineVR (Braun Medical, Sheffield, UK).
The proximal lumen of the bowel segment was also cannulated.
Continuous (non-pulsatile) perfusion was performed at 37C with
a mean pressure of 80 mmHg for 2 h in the first series of experi-
ments to validate segmental intestine EVNP, and extended to 4 h
in the second series of experiments to examine the impact of leu-
cocyte depletion on reperfusion injury using a white cell filter
(LeukoGuardVR RS; Pall Medical, Portsmouth, UK).
Outcome measures
Readings were taken for blood flow (ml/min), mean arterial pres-
sure (mmHg), pump speed (RPM) and temperature throughout
the perfusion. The bowel was visually assessed for quality of per-
fusion, including to the mucosa, mucosal oedema and peristalsis.
Random small bowel biopsy specimens were taken at the end of
cold ischaemia and the end of EVNP for histological assessments
to determine the severity of IR injury.
Luminal glucose stimulation
In the first series of experiments, after a 60-min equilibration pe-
riod, 50 ml of warmed 20 per cent glucose (D-(þ)-Glucose,
DextroseTM, Sigma Aldrich, Poole, UK) was infused over 1 min
into the bowel lumen. In the second series of experiments, small
bowel segments were infused with 50 ml of warmed solution of
20 per cent glucose (D-(þ)-Glucose, DextroseTM, Sigma Aldrich,
Poole, UK) over 1 min after 1 h and 4 h of EVNP. Venous samples
were taken at 0, 1, 5 and 10 min after finishing the first and sec-
ond infusion. Glucose levels were determined by electrochemical
means (Accu-ChekVR Aviva; Roche Diagnostics, Burgess Hill, UK).
Total glucagon-like peptide-1 (GLP-1) levels were determined by a
two-site microtitre plate-based immunoassay with electrochemi-
cal luminescence detection using a Meso Scale Discovery kit
(Gaithersburg, Maryland, USA).
Histopathology
A full-thickness biopsy specimen was taken from the isolated
segments of small bowel at different times (in situ, end of cold
ischaemic time and end of EVNP). The collected specimens were
fixed in 10 per cent formalin, processed to paraffin, sectioned at
4 mm and stained with haematoxylin and eosin. Samples were
assessed for markers and degrees of IR injury. Histopathological
Surgical relevance
Despite increasing recognition of the utility of ex vivo normothermic perfusion (EVNP) as an experimental and clinical technique,
there are no widely adopted methods for perfusion of intestinal segments. A successful technique is described. Beyond its potential
utility in investigation of intestinal physiology, function and pathology, such a validated experimental model could have applica-
tions to the field of intestinal transplantation where long-term outcomes remain poor. Ischaemia–reperfusion injury, rejection, in-
fection and graft-versus-host disease all play a role, and a segmental intestine EVNP model could potentially allow investigation of
the mechanisms underlying these pathologies and allow possible interventions to be investigated.
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assessment was performed blinded to experimental group iden-
tity. Histopathological assessment was based on villus height,
surface epithelial appearance, neutrophil infiltration and pres-
ence of intra-epithelial lymphocytes, scored individually in each
intestinal sample (Table 1).
Statistical analysis
Data are presented as mean(s.e.m.) unless otherwise stated.
Statistical analysis was performed using GraphPad PrismVR (ver-
sion 8.4; GraphPad, La Jolla, CA) and differences between time
points were analysed using non-parametric Friedman test or
Kruskal–Wallis test (in case of missing values), both followed
by Dunn’s multiple comparison test if significant. Small bowel
segments were randomly assigned to control and leucocyte-de-
pletion arms in the second series of experiments. The differen-
ces between time points were analysed using non-parametric
Friedman test followed by Dunn’s multiple comparison test.
The difference between the control and the leucocyte-depleted
group at the final time point was analysed using the two-tailed
Wilcoxon test.
Table 1 Histopathological scoring system for intestine ischaemia–reperfusion injury
Score Villus height Surface epithelium Neutrophil infiltration Intra-epithelial lymphocytes
0 Normal Intact None Normal
1 Some blunting Degenerate changes Localized in lamina propria Focal increase
2 Partial atrophy Some loss Focal crypt Diffuse increase
3 Subtotal atrophy Substantial loss Multifocal crypt
4 Lost Ulceration Crypt abscess
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Fig. 1 Ex vivo normothermic perfusion of isolated small bowel segments
a The ex vivo normothermic perfusion (EVNP) circuit utilizes paediatric venous bypass technology to perfuse isolated organs with normothermic oxygenated blood.
Representative appearance of intestinal segments b before and c 30 min after perfusion on the EVNP circuit. d Blood flow through the intestine segment stabilized
within 10 min of reperfusion. e Mean(s.e.m.) venous glucose in the EVNP circuit increased rapidly following administration of 20 per cent glucose into the lumen of
the intestine from 1.8(0.6) mmol/l to a peak of 15.5(5.8) mmol/l, P¼0.010 (Friedman test followed by Dunn’s correction for multiple comparisons). f Following
luminal glucose stimulation, total GLP-1 levels increased from a mean(s.e.m.) of 41.3(6.9) pg/ml to 98.0(29.4) pg/ml. Data are mean(s.e.m.); ** P 0.01.
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Results
Validation of segmental intestine EVNP
To validate segmental intestinal EVNP, one segment of small in-
testine was retrieved from each pig and perfused with autologous
blood on the EVNP circuit (Fig. 1a). The mean warm ischaemic
time, defined as the time between asystole and perfusion with
cold preservation solution, was 4.8 min (range 2–10 min). The
mean cold ischaemic time before the onset of EVNP was 5 h
20 min (range 3 h 42 min to 6 h 39 min). The cold ischaemic
time was the time taken for transport from the pig facility to the
experimental laboratory, as well as the time taken to surgically
prepare the intestinal segments for EVNP. All segments of bowel
(n¼ 4) were successfully perfused with no technical failures. All
bowel segments appeared well perfused with viable, non-
haemorrhagic mucosa throughout the perfusion with no
deterioration in the appearance of the organ at the end of the
experiment (Fig. 1b,c). Peristalsis was observed in all four bowel
segments (Video S1).
Mean(s.e.m.) blood flow during EVNP was 72(7.9) ml/min
(Fig. 1d). There was no difference in the blood flow between ani-
mals and no deterioration in flow during the course of the perfu-
sion. After 60 min of EVNP and 20 per cent glucose infusion there
was a rapid rise in venous glucose (Fig. 1e; less than 10 mins) and
GLP-1 (Fig. 1f; less than 15 mins).
Impact of leucocyte depletion on reperfusion
injury
The mean warm ischaemic time was 2.6 (range 2–4) min. The
mean cold ischaemic time before the onset of EVNP was 2 h
57 min (range 2 h 36 min to 3 h 36 min). All segments of bowel
(n¼ 10) were successfully perfused with no technical failures
(Fig. 2a). All bowel segments appeared well perfused with viable,
non-haemorrhagic mucosa throughout the perfusion, with no
deterioration in the appearance of the organ at the end of the ex-
periment.
There was no significant difference in the blood flow at the
end of 4 h of EVNP between the control and leucocyte-depleted
groups (Fig. 2b). Following the first intraluminal 20 per cent
glucose infusion after 60 min of EVNP, venous glucose levels
increased significantly compared to baseline levels both in the
control and the leucocyte-depleted groups (Fig. 2c). There were no
significant differences in venous glucose levels between the con-
trol and leucocyte-depleted groups at 10 minutes after the first
luminal stimulation (Fig. 2c). When absorptive function of the
small intestine was tested again at the end of the 4 h of EVNP
with a second intraluminal 20 per cent glucose infusion, when
baseline venous glucose concentrations were higher, there were
still no significant differences in venous glucose levels between
the control and leucocyte-depleted group at 10 minutes after the
second luminal stimulation (Fig. 2d).
Venous total GLP-1 levels were similar between the control
and leucocyte-depleted groups following the first intraluminal
20 per cent glucose infusion after 60 minutes EVNP (Fig. 2e) and
following the second intraluminal 20 per cent glucose infusion at
the end of 4 h of EVNP (Fig. 2f).
Histological assessment
Representative images of mild, moderate and severe degrees of
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Fig. 2 Impact of leucocyte depletion on intestine functional parameters on ex vivo normothermic perfusion
a Two segments of proximal to mid-ileum were retrieved from anesthetized pigs and transported in Soltran at 4C. Intestine segments were placed simultaneously
on two ex vivo normothermic perfusion (EVNP) circuits and perfused with either autologous whole blood (control) or autologous whole blood depleted of
lymphocytes (leucocyte and leucocyte-depleted). b There was no significant difference in the blood flow at the end of 4 h of EVNP between the control (n¼5) and
the leucocyte-depleted (n¼5) groups. c Following the first intraluminal 20 per cent glucose infusion after 60 min of EVNP, mean(s.e.m.) venous glucose levels
increased significantly compared to baseline levels both in the control group (21.6(2.2) mmol/l versus 11.6(0.7) mmol/l; P¼0.043) and the leucocyte-depleted group
(24.7(1.9) mmol/l versus 12.0(0.6) mmol/l; P¼0.008; Friedman test followed by Dunn’s multiple comparisons correction). c There were no significant differences in
venous glucose levels between the control and leucocyte-depleted groups after first luminal glucose stimulation or d after the second luminal glucose stimulation
at the end of 4 h of EVNP. Venous total GLP-1 levels following 20 per cent glucose infusion were similar in the control and leucocyte-depleted groups e after 60 min
or 4 h of EVNP. Data are mean6s.e.m.; * P0.05, ** P 0.01, *** P0.001.
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villus height, surface epithelium, neutrophil infiltration and in-
tra-epithelial lymphocytes are shown in Fig. 3a–c. AT the end of
4 h of EVNP, there were no significant differences between the
control group and the leucocyte-depleted groups in the histopa-
thology injury score for the small bowel tissue biopsy specimens
at the end of the cold ischaemic time or after EVNP (Fig. 3d).
Discussion
These experiments provide proof-of-concept evidence that blood-
based EVNP of porcine small bowel segments can be used to eval-
uate intestinal physiology, IR injury and pharmacology, including
drug absorption and therapeutic efficacy. The studies also dem-
onstrated that it is possible to obtain two consecutive segments
of small intestine from the same pig for simultaneous perfusion
on two EVNP circuits, enabling segments of small intestine from
the same animal to be used in both the control and treatment ex-
perimental arms.
No apparent differences between the consecutive segments of
the small intestine obtained from the same pig were observed,
acknowledging that detailed physiological or histological
comparisons were not undertaken. While recognizing that small
intestine anatomy and physiology changes along its length, it is
important that comparative experiments incorporate randomiza-
tion of proximal and distal segments to treatment and control
groups. It would be possible with the present system to reduce
the length of the intestine segment perfused to minimize varia-
tion in function between intestinal segments.
Increases in venous glucose and GLP-1 were seen consistently
following luminal glucose administration 60 min after the start
of EVNP. Although intraluminal stimulation with a glucose-de-
pleted control was not performed, the rapid time course and
magnitude of the response is consistent with specific responses
to stimulation. Glucose is actively absorbed from the intestine
into the blood by sodium-glucose transporter 1 (SGLT1)20 and glu-
cose transporter type 221. GLP-1 is an incretin produced from
intestinal L cells, that potentiates glucose-stimulated insulin
secretion by pancreatic b cells. Glucose-stimulated GLP-1
secretion into the blood is an active process, potentially also
mediated via SGLT122. The present results demonstrate both ac-
tive intestinal absorption and secretion during EVNP, confirming













































Fig. 3 Histological assessment of small bowel tissue biopsy specimens
a Low-grade injury (total score 1): top – normal villus height, normal surface epithelium and no neutrophil infiltration (haematoxylin and eosin (H&E) 4); bottom –
focal increase in intra-epithelial lymphocytes; score 1 (H&E 20). b Moderate-grade injury (total score 5): top – normal villus height and no neutrophil infiltration
(H&E 4); middle – substantial loss of surface epithelium; score 3 (H&E 20); bottom – diffuse increase of intra-epithelial lymphocytes; score 2 (H&E 20). c High-
grade injury (total score 11): top – some blunting in villus height; score 1 and ulceration of surface epithelium; score 4 (H&E 4); middle – crypt abscess of
neutrophil infiltration; score 4 (H&E 20); bottom – diffuse increase of intra-epithelial lymphocytes; score 2 (H&E 20). (D) There were no significant differences
between the control group (n¼5) and the leucocyte-depleted group (n¼5) in the mean(s.e.m.) histopathology injury score for the small bowel tissue biopsy
specimens at the end of the cold ischaemic time (CIT) (2.6(0.5) versus 3.6(0.7); P¼0.999) or after EVNP (6.2(1.0) versus 5.8(1.3) P¼ 0.999; Friedman test followed by
Dunn’s correction for multiple comparisons). There was no significant difference between the end of CIT and end of EVNP in both the control group (P¼0.165) and
the leucocyte-depleted group (P¼0.850, Friedman test followed by Dunn’s correction for multiple comparisons). Boxplot whiskers indicate minimum and
maximum values.
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In the existing model, the use of short bowel segments and a
circulating volume of 500 ml potentially allows three or four dif-
ferent experiments from a single pig, reducing costs and facilitat-
ing comparative experiments on different segments of the bowel.
It also enables the efficacy of a therapeutic intervention to be
compared to a control using two or more intestine segments
from the same pig and after identical warm and cold ischaemic
periods. Perfusion of small intestine segments with autologous
blood may be critical as previous studies using allogenic blood23–
28 reported significant mucosal sloughing and increasing perfu-
sion pressures, up to 200 mmHg, to maintain blood flow during
EVNP. The mucosa in all segments in the present experiments
remained pink and normal in appearance, with no evidence of
haemorrhage or sloughing.
There have been occasional reports of blood-based EVNP of
small bowel segments in dogs29,30 and humans31,32. Unlike pigs,
availability, cost and ethical concerns preclude their large-scale
experimental utility.
There were no significant differences between the control
group perfused with whole blood and the leucocyte-depleted
group in terms of blood flow, venous glucose, GLP-1 levels or his-
topathology at the end of 4 h of EVNP. The absence of a demon-
strable protective effect in the leucocyte-depleted group might be
partially explained by the short duration of EVNP (4 h). In addi-
tion, small bowel segments on the EVNP were not exposed to sys-
temic neurohormonal and immunological factors that influence
the severity of IR injury in clinical practice. Notwithstanding the
potential effects on cellular or immune markers that were not
assessed, the present study showed that, unlike kidneys undergo-
ing EVNP16,17, leucocyte depletion had no clear short-term func-
tional or histological effect on intestinal segments. The shorter
cold ischaemic times achieved in this series compared to earlier
validation studies were due to optimization of the surgical tech-
nique for preparation of the intestine segments for EVNP.
Beyond the current experiments, significant refinements can
still be made to the retrieval technique and perfusion conditions
that should allow prolonged perfusion and more detailed assess-
ment of intestinal function and viability. The technique, however,
provides a cost-effective, practical and reliable model for the
study of intestinal physiology, pharmacology and transplantation.
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